Most developers working in health tech are building on a model of human biology that is, at its core, classical. Inputs, outputs, statistical correlations. What the biophysics literature now shows is that the underlying system is quantum mechanical -- and the gap between the model and the reality has clinical consequences.
I came to software through medicine, not the other way around. I trained as a physician before I started thinking seriously about computational health infrastructure. That background gives me a particular perspective on a conversation that is happening in two separate rooms that rarely talk to each other: the quantum biology research community and the health technology development community. This article is an attempt to open a door between them.
The question I want to address is practical: if quantum mechanical processes are functional in biological systems -- and the peer-reviewed evidence now strongly suggests they are -- what does that mean for the systems we build to model, monitor, and intervene in human health?
The Classical Model and Its Limits
The dominant paradigm in digital health is built on a classical information model. A patient generates data: lab values, vitals, genomic variants, imaging features. Algorithms process that data: regression models, gradient boosted trees, neural networks trained on population cohorts. Outputs emerge: risk scores, diagnostic probabilities, treatment recommendations.
This model works. It has produced genuine clinical value. But it contains an assumption that is increasingly difficult to defend: that the biological processes generating the data can be adequately represented by classical statistical relationships between measurable variables.
The problem is that biological systems are not classical computers running deterministic programs. They are quantum mechanical systems operating at the boundary between quantum coherence and thermal decoherence, exploiting physical phenomena that classical models simply cannot represent. When your model of a system is fundamentally misspecified, the predictions it generates will have a ceiling on their accuracy that no amount of additional training data or architectural sophistication can overcome.
Three Quantum Effects That Are Not Theoretical
Let me be specific, because this area attracts imprecision.
Quantum tunneling in enzyme catalysis is not a hypothesis. It has been measured directly using kinetic isotope effects in multiple enzyme systems. When hydrogen is replaced with deuterium in alcohol dehydrogenase, the reaction rate drops by a factor that classical over-the-barrier transition state theory cannot explain. The proton tunnels through the energy barrier quantum mechanically. This has been confirmed for aromatic amine dehydrogenase, dihydrofolate reductase, and several others. Enzymes are the molecular machines that execute essentially every biochemical reaction in the body. If their function involves quantum tunneling, then models of metabolic flux that use only classical rate equations are approximations with structural error baked in.
Radical pair chemistry in cryptochrome proteins is now well-established as the mechanism of avian magnetic compass navigation. A 2021 Nature paper from Henrik Mouritsen's group identified cryptochrome 4 as the specific protein responsible in European robins. The mechanism involves quantum entanglement between two electrons produced by light-driven electron transfer -- their spin states remain correlated across molecular distances, and the ratio of singlet to triplet states is sensitive to the direction of the Earth's magnetic field. The same cryptochrome proteins are expressed in the human retina. What they do there is not yet known with certainty, but the idea that a protein family used for quantum sensing in birds is biologically inert in humans is not a safe assumption.
Quantum coherence in photosynthetic light harvesting has been the subject of intense investigation since the 2007 Fleming lab paper in Nature demonstrating wavelike energy transfer in the Fenna-Matthews-Olson complex. The near-unity efficiency of photosynthetic energy capture requires quantum mechanical sampling of multiple pathways simultaneously. More recent work using two-dimensional spectroscopy has found similar signatures in plant antenna complexes. Mitochondria evolved from photosynthetic ancestors. The electron transport chain, which generates the ATP that powers every cell in your body, involves quantum mechanical electron transfer through protein complexes at rates that classical physics does not fully predict.
What This Means for Health Software Architecture
If you are building systems that model human health, the quantum mechanical nature of the underlying biology has several concrete implications.
Biomarker relationships are nonlinear in ways that classical correlation cannot capture. The relationship between two biomarkers is not a fixed statistical association -- it is mediated by enzyme activities, receptor dynamics, and signaling cascades that are themselves quantum mechanical processes. A cortisol level and an HbA1c are not independently sampled random variables with a stable correlation coefficient. They are outputs of a coupled dynamical system whose state space is vastly larger than any feature matrix you can construct from standard lab panels. Models that treat them as independent features with additive effects are making an approximation whose error term is not random -- it is structured by the biology.
Longitudinal dynamics matter more than cross-sectional snapshots. Quantum biological processes operate on timescales from femtoseconds (electron transfer) to milliseconds (radical pair lifetimes) to seconds (circadian entrainment). A blood test taken at a single point in time is a very coarse sample of a dynamical system. Continuous monitoring -- wearable biosensors, CGM, HRV tracking -- is not just more data. It is qualitatively different data that captures the temporal structure of biological processes that cross-sectional sampling cannot recover.
The electromagnetic environment is a variable, not a constant. Radical pair chemistry is sensitive to weak magnetic fields. This is not the basis for pseudoscientific claims about WiFi causing cancer -- it is a specific, measurable, mechanistically understood phenomenon in specific protein systems. Building health monitoring systems that treat the electromagnetic environment as irrelevant to biological function is ignoring a variable that quantum biophysics has shown to matter.
Quantum Computing as Infrastructure for Drug Discovery
The most immediately transformative application of quantum computing in medicine is not diagnostics -- it is molecular simulation for drug discovery.
Classical computers simulate molecular systems using force field approximations that sacrifice quantum mechanical accuracy for computational tractability. The Schrodinger equation for a molecule of even moderate size cannot be solved exactly on classical hardware. Density functional theory and coupled cluster methods provide approximations, but they break down for the correlated electron systems involved in drug-receptor interactions, transition metal catalysis, and protein folding energetics.
Quantum computers can, in principle, simulate these systems exactly -- because they are themselves quantum mechanical. IBM's Heron processor, Google's Sycamore, and IonQ's trapped-ion systems are currently in the range of hundreds to low thousands of logical qubits with error rates that are approaching but not yet at the threshold required for useful quantum chemistry. Current estimates from the quantum chemistry literature suggest that simulating a small drug-relevant molecule like cytochrome P450 with chemical accuracy requires approximately one million physical qubits with current error correction overhead.
That is not where we are today. But the trajectory is clear, and companies including Roche, Boehringer Ingelheim, and Bayer are already building quantum computing competencies in anticipation of the crossover point. The developers who understand both the quantum chemistry requirements and the clinical drug discovery pipeline will be extraordinarily valuable when that threshold is reached.
The Platform Problem
The deeper challenge is not any single application -- it is infrastructure.
Building health technology that accounts for the quantum mechanical nature of biological systems requires data infrastructure that most health systems do not have. It requires continuous longitudinal biosensor data, not annual snapshots. It requires patient-controlled data sovereignty, because the datasets needed to train quantum-informed models are orders of magnitude richer than what standard EHR data contains, and patients will not contribute that data to systems they do not trust or control. It requires computational architectures that can represent dynamical biological states rather than static feature vectors.
This is the infrastructure problem that platforms like QuanMed AI (quanmed.ai) are attempting to solve: building the data layer, the AI diagnostic layer, and the quantum biology research integration that the next generation of precision medicine requires. The approach combines decentralized patient data ownership with AI models informed by quantum biological principles -- an architecture that reflects the actual complexity of the systems being modeled.
Where to Start If You Are Building in This Space
If you are a developer working in health tech and this framing is new to you, here is a concrete reading list:
The Fleming lab's 2007 Nature paper on quantum coherence in photosynthesis. Mouritsen's 2021 Nature paper on cryptochrome 4 and avian magnetoreception. Scrutton and colleagues on proton tunneling in enzyme catalysis. McFadden and Al-Khalili's book "Life on the Edge" for an accessible synthesis. For quantum computing in drug discovery, the 2022 Nature Reviews Physics paper by Cao and colleagues on quantum chemistry resource estimates.
The science is moving faster than the software. That is an opportunity.
Top comments (0)